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PathophysiologyMitochondrial glycerol-3-phosphate dehydrogenase (mGPDH) is not included in the traditional textbook
schemes of the respiratory chain, reﬂecting the fact that it is a non-standard, tissue-speciﬁc component of
mammalian mitochondria. But despite its very simple structure, mGPDH is a very important enzyme of in-
termediary metabolism and as a component of glycerophosphate shuttle it functions at the crossroads of gly-
colysis, oxidative phosphorylation and fatty acid metabolism. In this review we summarize the present
knowledge on the structure and regulation of mGPDH and discuss its metabolic functions, reactive oxygen
species production and tissue and organ speciﬁc roles in mammalian mitochondria at physiological and path-
ological conditions.
© 2012 Published by Elsevier B.V.1. Introduction
It is hard to believe that the research on the mitochondrial glycerol-
3-phosphate dehydrogenase (mGPDH) started already 75 years ago [1]
and yet there are still many questions to be answered, both concerning
the structure/function relationship and regulation of this enzyme. This
becomes even more striking when we consider its simple structure.
With only one 74 kDa subunit, mGPDH is the simplest component of
the mammalian respiratory chain.
mGPDH is an integral component of the mammalian respiratory
chain and glycerophosphate (GP)-shuttle connects mitochondrial
and cytosolic processes and plays an important role in cell bioenerget-
ics, both under physiological and pathological conditions. GP-shuttle
function depends on a highly variable expression of mGPDH in various
mammalian tissues. It can be regulated by two mechanisms — by the
content of mGPDH protein, because cytosolic cGPDH is not rate limit-
ing for GP-shuttle function and by allosteric regulation of mGPDH ac-
tivity by several metabolites or ions. However, it is still not completely
understood why mGPDH expression is so highly suppressed in mostnt glycerol-3-phosphate dehy-
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sevier B.V.mammalian tissues and what is the real reason for extremely high
mGPDH activity in others.
Three possible metabolic roles for high mGPDH/GP-shuttle func-
tion have so far been suggested: (i) reoxidation of cytosolic NADH in
glycolytic cells; (ii) bypassing complex I during cytosolic NADH oxida-
tion with possible implications in thermogenesis and/or metabolic ef-
ﬁciency; and (iii) regulation of cytosolic glycerol-3-phosphate (G3P)
as metabolite connecting glycolysis, lipogenesis and oxidative phos-
phorylation (OXPHOS).
Another important feature we will focus on is the reactive oxygen
species (ROS) generation by mGPDH that is not sufﬁciently protected
against electron leak and could also facilitate ROS production at other
sites of the respiratory chain. This may also be one of the reasons why
in most tissues its expression is suppressed.
Finally we will discuss tissue or organ-speciﬁc aspects of mGPDH
metabolic involvement at physiological and pathological states which
enables us to deﬁne the speciﬁc roles of this enzyme in mammalian
organism.
2. Simple, yet unclear structure and reaction mechanism
of mGPDH
Mitochondrial glycerol-3-phosphate dehydrogenase is a ﬂavin-
linked respiratory chain dehydrogenase that oxidizes glycerol-3-
phosphate (G3P) to dihydroxyacetone phosphate (DAP) (redox
potential−190 mV) with concurrent reduction of ﬂavin adenine dinu-
cleotide (FAD) to FADH2 and transfers electrons to coenzyme Q (CoQ).
Mammalian mGPDH is encoded by a single GPD2 gene located on
chromosome 2 in human and chromosome 3 in rat. It is a conserved
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high degree of homology with yeast, insect and bacterial ﬂavin-linked
G3P dehydrogenases. On the other hand, there is no homology with
the cytoplasmic NAD-linked glycerol-3-phosphate dehydrogenase
(cGPDH) encoded by GPD1 gene, the soluble dehydrogenase that re-
duces DAP to G3P while oxidizing cytosolic NADH (Fig. 1).
Rat mGPDH is synthesized as 79 kDa precursor that is processed to
~74 kDa mature protein upon removal of the N-terminal (~5 kDa)
presequence, after the import into mitochondria [2–4]. Following the
early attempts to isolate mGPDH [5,6], mammalian enzyme was iso-
lated from several tissues of rat, pig or rabbit [2,7–9] yielding in best
cases very puremGPDHproteinwith varying content of noncovalently
bound FAD, non-heme Fe and acid-labile sulﬁde that ranged from
substoichiometric amounts to approximately onemolecule of cofactor
and acid-labile sulﬁde per mol of enzyme [2,7,10]. This is a uniquely
low content of prosthetic groups (cofactors) among mitochondrial
electron transport enzymes that mirrors the simple structure of
mGPDH comparable with rubredoxin oxidase of the strict anaerobe
Desulfovibrio gigas [11,12]. Despite the early studies indicating the
presence of non-heme iron, there is no FeS center present in the crys-
tal of bacterial enzyme and neither there is consensus CxxCxxC motif
for 4Fe4S center coordination in the sequence of mammalian protein.
Therefore FAD is most likely the only prosthetic group present in
mGPDH.
As the crystal structure of mammalian mGPDH is not yet available,
the membrane topology can only be deduced from the hydropathy
plot of amino acid sequence, biochemical studies and 3-D structure
of its bacterial homologue GlpD [13] or closely related bacterial G3P
oxidase (GlpO) [14].Fig. 1.mGPDH and its place in intermediary metabolism. Enzymes constituting GP-shuttle a
ing from lipolysis. Part of the malate/aspartate-shuttle as an alternative pathway of reducin
tory chain are in green with yellow arrows indicating ﬂow of electrons through the OXPHOS
ETF DH — ETF:Q dehydrogenase, FFA — free fatty acids, G3P — glycerol-3-phosphate, DAP —Crystal structures of bacterial GlpD from E. coli [13] and GlpO from
Streptococcus sp. [14] suggest anchoring to the membrane without
transmembrane helices and the presence of dimeric form of enzyme
that interacts through the hydrophobic regions, supporting the view
that mGPDH is strongly associated with the inner membrane but
rather as a peripheral, than an integral protein. Although this fold is
rather unusual it is shared with another dehydrogenase communicat-
ing with the CoQ pool — electron transfer ﬂavoprotein (ETF):Q dehy-
drogenase [15,16] and several other enzymes utilizing hydrophobic
ligands. All these proteins share structural motifs that run parallel to
the membrane surface and form apolar plateaus that are hypothe-
sized to bury into one leaﬂet of the membrane only [17]. This view
is also supported by the fact, that yeast mGPDH is extracted from
the membrane by carbonate but not by high salt treatment implying
that the enzyme is peripheral and holds in the membrane by hydro-
phobic interactions [18].
Nevertheless detailed structural information for themammalian en-
zyme is still missing. Given the relatively good sequence conservation
between mammalian and bacterial enzyme (30% identity and 48% sim-
ilarity), it has most likely monotypic structure as well. The C terminal
Ca2+ binding domain is not present in the bacterial enzyme and its
structure is unclear. It should be noted that early studies of MacDonald
and Brown [19], predicted three transmembrane segments in the N ter-
minal third of the protein with the long C-terminal region exposed to
the intermembrane space. However, this fold which was based on von
Heine's algorithm [20] is rather unlikely, as parts of the predicted
transmembrane helices comprise FAD binding site which is very well
conserved from the bacterial enzyme and presumably has the same
fold not protruding the membrane. Some of the hydrophobic parts,re depicted in blue as well as glycerol kinase (GK) which phosphorylates glycerol com-
g equivalents transport is depicted in orange. Complexes of the mitochondrial respira-
. Q— Coenzyme Q, CI— complex I, CII— complex II, CIII— complex III, CIV— complex IV,
dihydroxyacetone phosphate.
403T. Mráček et al. / Biochimica et Biophysica Acta 1827 (2013) 401–410predicted to be transmembrane regions according to the hydropathy
plot are most likely present on the surface of the protein and represent
structural prerequisite for protein dimerization [13].
Kinetic properties of isolated mGPDH revealed 2.9 mM Km for G3P
and ~7 μMKm for FAD in rat liver enzyme [2]. Afﬁnity to G3Pwasmod-
ulated by Ca2+ with the maximal activation at [Ca2+] 10−4–10−5 M
[21]. Interaction of rabbit brainmGPDHwith electron acceptors showed
high afﬁnity for CoQ0 and CoQ1 with Km ~10–48 μM depending on the
stage of puriﬁcation, while Km for decylbenzoquinone analog was too
low to measure [10].
Mechanistically, 2-hydroxy group of glycerol-3-phosphate is oxi-
dized, forming dihydroxyacetone phosphate. Electron pair is trans-
ferred to prosthetic FAD forming FADH2 and these two electrons are
subsequently transferred to decylubiquinone forming decylubiquinol
in the membrane. Assuming that there is no Fe–S center in mammali-
an mGPDH (in contrast to succinate dehydrogenase (SDH) or ETF:Q
dehydrogenase) the reaction mechanism may be similar to that of
the bacterial enzyme, where FAD and CoQ binding sites are closely ap-
posed and electron transfer from FADH2 to CoQ is mediated through
protein residues or by a ping–pong interaction of the product DAP
and CoQ with the FADH2 [13].
3. Transcriptional regulation, unique tissue speciﬁcity and
response to thyroid hormone
Mitochondrial content of OXPHOS complexes and mobile elec-
tron carriers is known to vary according to different metabolic needs
and energy demands speciﬁc for individual tissues [22]. Individual
OXPHOS subunits show a high degree of coexpression to ensure con-
certed changes of the OXPHOS machinery as a functional unit and
such regulation is achieved through generalized transcription factors
such as NRF1, NRF2, and YY1 [23]. On the contrary, mGPDH shows
an extremely high variation in tissue expression levels and its tissue
content and activity are considerably different from those of other
OXPHOS proteins. There are up to two-orders of magnitude differ-
ences in mGPDH content between mammalian tissues [24–27]. The
highest levels were found in brown adipose tissue (BAT), muscle and
brain and the lowest in liver or heart, although heart has similarly
high oxidative capacity as BAT. Apart from these extremes, there are
also other tissues where mGPDH plays an important role, namely β
pancreatic cells [28,29], testis [19,30], placenta [8,31], aswell as in var-
ious glycolytic cells, e.g. ﬁbroblasts [32].
Expression of mGPDH is regulated predominantly at the transcrip-
tional level [26,30,33,34]. GPD2 gene spans 100 kb and consists of 17
exons. The use of alternate promoters was suggested by the presence
of three different ﬁrst exons that are expressed in a tissue-speciﬁc
manner. Exon 1a is found primarily in the brain, exon 1b is used in
all tissues, and exon 1c is detected predominantly in the testis.
Depending on the tissue, different transcript lengths in rat were thus
observed: 5.9 kb in all tissues, 3.6 kb in skeletal muscle, and 2.5 kb
in testis. The length isoforms are attributable to alternate splicing
and polyadenylation site use. Transcription of mGPDH is activated by
TR/RXR binding to TRE (thyroid hormone response elements) se-
quence in promoter region of GPD2 gene [35]. Thyroid hormone
(3,5,3′-tri-iodo-L-thyronine, T3) and steroid hormone but not the per-
oxisome proliferator cloﬁbrate or retinoic acid activate the ubiquitous
promoter B in a receptor-dependent manner, suggesting that tissue-
speciﬁc factor(s) contribute to the tissue-restricted responsiveness
to thyroid hormone. The other two more tissue-restricted promoters
A and C are not inducible by these hormones. Interestingly, human
mGPDH promoter B is not regulated by T3, which is the ﬁrst example
of a differentially T3-regulated orthologous gene promoter in man
and rat [35].
Following the ﬁrst observation that T3 activates mGPDH synthesis
in the liver but not in other tissues [36], the relationship between hor-
mone dose, receptor occupancy and mGPDH synthesis was studied inthe liver of euthyroid and hypothyroid rats [37]. Up to 10-fold differ-
ence in mGPDH mRNA levels was observed between hypo- and hy-
perthyroid states [38] and T3 induction of mGPDH showed rather
fast response in transcript (6–12 h) and protein (24 h) synthesis
[38,39] resulting in ~3-fold increase in mGPDH activity and content.
Interestingly, mGPDH showed half life of 60 h indicating relatively
fast turnover of this dehydrogenase compared with other proteins
of mitochondrial inner membrane.4. Glycerophosphate shuttle — a crossroad of glycolysis, fatty acid
metabolism and oxidative phosphorylation
Studies of metabolic function of mGPDH started in 1936 by Green
and coworkers [1,40,41] who found that this enzyme is present in
variable amount in many mammalian tissues. The highest enzyme
activity was found in mammalian BAT [42] and in insect ﬂight mus-
cles [43,44]. It was also the insect ﬂight muscle, where the role of
mGPDH was ﬁrst studied; Zebe and McShan reported a very high ac-
tivity of mGPDH accompanied by a low activity of lactate dehydroge-
nase [45] and Kubista observed low production of lactate and high
production of G3P during an intensive ﬂight muscle activity [46].
Subsequently two groups independently proposed a new metabolic
cycle — glycerophosphate shuttle [47–49].
The GP-shuttle is formed by two glycerol-3-phosphate dehydroge-
nases, namely cytosolic cGPDH that is soluble and NADH-dependent
(E.C.1.1.1.8), and by mitochondrial, membrane-bound, FAD-dependent
mGPDH (E.C. 1.1.5.3). They catalyze conversion of DAP and G3P and
vice versa coupled with oxidation of cytosolic NADH and reduction of
FAD in the mitochondrial enzyme (Fig. 1). The main metabolic role of
this shuttle is reoxidation of cytosolic NADH produced by glycolysis.
This enables sustained rate of cytosolic ATP production without accu-
mulation of an intermediate by-product such as lactic acid. Insect ﬂight
muscle can therefore contract without acidiﬁcation for as long as glyco-
gen is available. This mechanism also leads to transport of reducing
equivalents (hydrogen) from cytosol into mitochondria where they
can be utilized for aerobic mitochondrial ATP production. GP-shuttle
was not considered to be of a general importance because functional ac-
tivity of the cycle requires equimolar proportions of both components of
the cycle — mitochondrial and cytosolic G3P dehydrogenases and in
most tissues the content of mGPDH is relatively low in comparison
with the cGPDH. GP-shuttle therefore appeared to be only secondary
to malate/aspartate-shuttle.
Increasing interest in GP-shuttle started when active GP-shuttle
was described in mammalian BAT [24]. It had been already known
that brown fat mitochondria have unusually high activity of mGPDH
[42], but in this study it was demonstrated that both mGPDH and
cGPDH are highly active and in equimolar proportions, which is pre-
requisite for the functional activity of the shuttle. Therefore it was
suggested that the shuttle could play an important role in BAT metab-
olism supporting cytosolic ATP generation by NADH reoxidation. Cy-
tosolic ATP production in BAT is important despite the high rate of
fatty acid oxidation as mitochondria contain only tiny amount of ATP
synthase [50,51] and all energy generated by OXPHOS is released by
the action of uncoupling protein (UCP1) as heat [52]. Simultaneously,
similarly to insect muscle cells, GP-shuttle may support thermogenic
function of BAT mitochondria by transport of additional reducing
equivalents formed in cytosol (NADH). It was also proposed that
GP-shuttle may be involved in the regulation of cytosolic G3P avail-
ability for triglyceride synthesis. Esteriﬁcation of G3P to acylglycerol-
phosphate is the ﬁrst and rate-limiting step of the lipid synthesis
[53]. mGPDH and G3P acyltransferase compete for the same substrate
and due to its very high activity in BAT, mGPDH can signiﬁcantly inﬂu-
ence concentrations of the available G3P. Thus the mGPDH has two
important roles in BAT: (i) control of cytoplasmic NADH level and
(ii) control of triglyceride and phospholipid synthesis through regulation
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termediary metabolism is summarized in Fig. 1.
Oxidation of NADH by GP-shuttle is energetically “inefﬁcient”
when compared to NADH oxidation by complex I, as mGPDH has
no proton pumping activity. These ﬁndings stimulated interest in
mGPDH as factor participating in processes of heat dissipation and en-
ergy balance regulation of mammalian organism [54]. In this respect,
phenotype of Lou/C rat is particularly interesting. This rat shows pro-
nounced resistance to age or diet induced obesity most likely due to
increased mGPDH expression in liver caused by high TRα1 expres-
sion [55]. Partial dissipation of energy via channeling of cytosolic
NADH through GP-shuttle instead of malate/aspartate-shuttle may
therefore represent an attractive target for obesity treatment.
5. Allosteric regulations of mGPDH
As an important enzyme of intermediary metabolism, mGPDH
shows complex regulation by a range of activators and inhibitors.
The most important endogenous activator is calcium [19,49,56]. In-
deed, mGPDH has a calcium binding site containing the canonical EF
hand motif for coordination of Ca2+ [57] and binding of Ca2+ de-
creases Km for substrate. Ca2+ binds to the protein moiety exposed
to intermembrane space because its effect is not inhibited by the ru-
thenium red, an inhibitor of calcium transport through the mitochon-
drial membrane [58]. To a certain extent, activating effect was also
observed for other bivalent cations such as Mg2+ [8], Mn2+ [56] and
Cd2+ [59].
Competitive inhibitory effect of mGPDH activity was described for
various phosphoderivates of glycerol such as L- and D-glyceraldehyde-
3-phosphate, D-phosphoglyceric acid and D-glycerol phosphate
[31,60,61]. This indicates the importance for a strict regulation of the
enzyme standing at the crossroads between glycerol oxidation and
its utilization for lipid biosynthesis. However, precise regulatory feed-
back loops in vivo remain unclear.
The regulatory role of free fatty acids (FFA) and their acyl-CoA es-
ters is also very important. While the inhibition by palmitoyl-CoA is
of a competitive type [62], FFA display non-competitive inhibition,
which is completely reversible by extraction of FFA by serum albumin
[63]. Endogenous fatty acids often inhibit mGPDH activity in mito-
chondrial preparations as they bind to the mitochondria during the
isolation process. Such inhibition can be released by FFA oxidation
after addition of malate, carnitine and ATP [64]. The inhibitory effect
or FFA was localized as inhibition of the transfer of electrons from
the enzyme to CoQ as the oxidoreductase activity (acceptor oxygen
or cytochrome c) was inhibited whereas dehydrogenase activity
(acceptor phenazine methosulfate) was insensitive to FFA addition
[65]. The regulation of mGPDH activity by FFA is very important espe-
cially in cells with high mGPDH content. High activity of GP-shuttle
can deplete cytosolic concentrations of G3P and thus inhibit the rate
of triglyceride and phospholipid synthesis. Suppressed oxidation of
G3P by FFA and acyl-CoA therefore allows their esteriﬁcation. We
may conclude that both FFA and their acyl-CoA esters are strong but
reversible inhibitors of mGPDH and can efﬁciently regulate both
GP-shuttle activity and rate of lipid synthesis.
Studies of molecular mechanism of FFA inhibitory action demon-
strated that FFA can act also indirectly through the modiﬁcation of
the state of the lipid bilayer. These inhibitory effects correlated with
changes in membrane microviscosity monitored by the steady-state
ﬂuorescence anisotropy of ﬂuorescent probe 1,6-diphenyl-1,3,5-
hexatriene [66]. This was further conﬁrmed by experiments with iso-
lated enzyme incorporated into liposomes with different proportions
of saturated and unsaturated fatty acids in phospholipids. mGPDH
showed maximum activity within a narrow range of the membrane
lateral pressure and both decrease and increase of membrane ﬂuidity
had an inhibitory effect [67]. mGPDH thus belongs to the group of
membrane-bound enzymes with activities modiﬁed by the state oflipid membrane phase and also by phospholipid composition-
dependent surface charge [68]. In yeast, photolabeling with phospha-
tidylcholine analog demonstrated close association between mGPDH
and phosphatidylcholine [18]. Existence of such association was fur-
ther demonstrated by the fact that phosphatidylcholine depletion
reduced growth on glycerol and increased glycerol excretion. Phos-
phatidylcholine therefore seems to be necessary for optimal mGPDH
functioning in vivo. Authors proposed that low phospholipid content
downregulatesmGPDH and free G3Pmay then be used for triglyceride
and phospholipid synthesis instead of mitochondrial oxidation [69].
When mGPDH was puriﬁed from mammalian mitochondria [2,6],
it was also found that the enzyme has a number of functionally im-
portant SH groups. Its activity can therefore be inhibited by various
SH modifying agents such as mercurials and maleimides [70]. Other
strong inhibitors are dicarbanonaborates. The inhibition by mercapto-
dicarbanonaborate is of a competitive type and completely reversible
by serum albumin [71]. However, no inhibitor is available yet that
would be highly speciﬁc for mGPDH and without effect on other respi-
ratory chain enzymes.
6. What are the sites of glycerol-3-phosphate-dependent
ROS production?
Although complexes I and III of the respiratory chain are widely
considered as primary sources of mitochondrial reactive oxygen spe-
cies (ROS), an important role of mitochondrial ﬂavin dehydrogenases
in ROS production has been established over the recent years [72].
mGPDH was indeed the ﬁrst of these dehydrogenases to be charac-
terized as ROS producer [73–75], but further studies identiﬁed
α-ketoglutarate dehydrogenase [76], ETF:Q dehydrogenase [77] and
succinate dehydrogenase [78] to contribute to overall ROS production
as well. Levels of ROS production frommGPDH are very high and com-
parable with maximum rates for complex III when inhibited with
antimycin A [79–81]. Furthermore, a signiﬁcant G3P-dependent ROS
production has been described even in mitochondria from tissues
with very low mGPDH content where the amount of ROS produced
relatively to the mGPDH enzyme activity tends to be extremely high.
This makes mGPDH a potentially important ROS source in typically
aerobic tissues with negligible enzyme content such as the heart [27].
Detailed molecular mechanism of electron leak from mGPDH as
well as other ﬂavin dehydrogenases is still missing and there may be
considerable differences among individual enzymes. In many cases
the observed, substrate-dependent ROS production cannot be even
ascribed to the respective dehydrogenase per se. In principle three
modes of ROS production can be envisaged: (i) ROS production on
the other dehydrogenases connected to the Q pool; (ii) production
on the respective dehydrogenase; and (iii) production on the com-
plexes downstream of the Q pool (i.e. typically at the level of complex
III). The key question is whether or not the given ROS production
mode can occur in vivo. See Fig. 2 for schematic explanations of possi-
ble electron transfer pathways and respective places of ROS produc-
tion in the respiratory chain under all the modes proposed.
6.1. ROS production at complex I and SDH
Under these conditions the real source of ROS may not be dehy-
drogenase itself but another enzyme communicating with the Q
pool. Originally this was described as reverse electron transfer (RET)
towards complex I under high levels of mitochondrial membrane po-
tential ΔΨ and low ﬂux through the respiratory chain, typical for mi-
tochondria in respiratory state 4. Indeed, reverse ﬂow of electrons is
considered to be main source of SDH-dependent ROS at high ΔΨ
levels [82]. RET seems to play role in G3P-dependent ROS production
as well but the extent varies between tissues and experimental
models. Signiﬁcant RET was observed in brain mitochondria respiring
on G3P [83], but it was less pronounced in Drosophila mitochondria
Fig. 2. Possible sites of glycerol-3-phosphate-dependent ROS generation. ROS may be produced on the dehydrogenase itself as well as other sites of OXPHOS enzymes. All sites that
may be responsible for G3P-dependent ROS generation are marked with red stars. Other sites of mitochondrial ROS production not associated with mGPDH are indicated with red
outlined stars. Traditional way of electron ﬂow through individual complexes is indicated by blue arrows. However, ROS production may be the result of reverse electron transport
from mGPDH to CI or SDH as indicated by yellow arrows. Sites of mGPDH interaction with artiﬁcial electron acceptors (PMS, FeCN) are also indicated. PMS — phenazine
methosulfate, CI— complex I, CIII— complex III, SDH— succinate dehydrogenase, FeCN— ferricyanide, FFA— free fatty acids, G3P— glycerol-3-phosphate, DAP— dihydroxyacetone
phosphate, Q — coenzyme Q.
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[27,84]. As RET from mGPDH is highly ΔΨ dependent, part of the
explanation may be loose coupling of BAT mitochondria. This is
supported by the observations that ROS production was higher in
UCP1−/− animals under both succinate and G3P [85,86]. RET also de-
pends on G3P concentration and is more pronounced at high G3P
concentrations (40 mM) [83]. It is however unlikely that these con-
centrations may occur in vivo. Interesting observation supporting ex-
istence of at least some G3P-dependent RET is that G3P addition to
BAT mitochondria leads to increase in reduction state of NAD(P)H
pool which is slowed down by the addition of rotenone [87].
Other example of reverse electron ﬂow was described recently. In
skeletal muscle mitochondria, part of mGPDH-dependent ROS pro-
duction may happen at the level of ﬂavin in SDH, due to reverse elec-
tron ﬂow via Q pool [78,88]. This mechanism also explains the
paradoxical phenomenon, where very high G3P-dependent ROS pro-
duction was observed in tissues with low mGPDH content [27]. It is
most likely that under these conditions the real source of electron
leak was ﬂavin in SDH [88]. However, this type of reverse ﬂow was
demonstrated when succinate was not present in the solution and it
is not clear how forward and reverse electron ﬂow would compete
in SDH in vivo. The physiological importance of this phenomenon
thus remains to be established.
6.2. Electron leak at mGPDH
The principal source of electron leak may be the dehydrogenase it-
self. Here, ﬂavin, or semiquinone is a possible site for ROS generation
by mGPDH. Flavin has been proposed as the source of electron leak
in the case of SDH operating in forward mode [78]. This type of leakrequires low succinate concentrations and only partial occupancy of
ﬂavin site of SDH by succinate. This is in contrast with mGPDH,
where ROS production increases linearly with increasing GP concen-
tration [83] and superoxide is produced on both sides of the mem-
brane [79,88]. The most likely source of ROS in mGPDH is therefore
the Q site. This is supported by several lines of evidence. The reactive
site of mGPDH is located rather superﬁcially and CoQ docking occurs
at the planar region facing the lipid bilayer, similar to ETF:Q dehydro-
genase, which has also been described as ROS producer [16,77,87].
This is in marked contrast with SDH where the presence of the deep
coenzymeQ-binding pocket represents a natural protection by stabili-
zation of ubisemiquinone radical formed during coenzyme Q reduc-
tion [89,90]. Of note here is the fact that mutations in CoQ binding
site of SDHC subunit lead to signiﬁcant increase in ROS production
[91]. Insufﬁcient stabilization of semiquinone in case of mGPDH thus
seems to be the most likely source of electron leak. Interestingly solu-
ble CoQ1 does have strong antioxidant effect in the case of solubilized
mGPDH [75] while it acts pro-oxidatively with SDH. Indeed observed
induction of substrate-dependent ROS production by ferricyanide in
membrane bound as well as isolated mGPDH, apparently absent in
succinate-dependent ROS production, implicates that facilitation of
one-electron transfer from mGPDH highly stimulates electron leak.
This is also completely inhibited by CoQ1 [75] or another one electron
acceptor hexaammineruthenium chloride, implying that all these
compounds compete for the same binding site [92]. In the context of
ping–pong reaction mechanism, it is likely, that FADH2 is formed dur-
ing catalysis. Under normal conditions the transfer of electrons to CoQ
is concerted two electron process, while transfer of one electron to fer-
ricyanide leads to formation of ﬂavin semiquinone, which subse-
quently reacts with molecular oxygen producing superoxide [75].
406 T. Mráček et al. / Biochimica et Biophysica Acta 1827 (2013) 401–4106.3. ROS production at complex III
The last source may be complex III. This is signiﬁcant after an-
timycin A addition but of questionable physiological relevance as
blockade of electron transport in respiratory chain alone is not sufﬁ-
cient for ROS production at the level of complex III. G3P-dependent
ROS production at the level of complex III seems to be highly tissue de-
pendent and generally inversely correlated to the content of mGPDH.
In BAT low decrease of measured ROS production after myxothiazol
versus antimycin A addition indicates low involvement of complex
III [81]. On the contrary complex III component seems to be signiﬁ-
cant in tissues with low mGPDH content such as the kidney or heart
[27,72].
7. Can mGPDH form higher structures?
Mitochondrial inner membrane is very rich in proteins and tends
to be highly organized and it is tempting to study association of
mGPDH into higher order assemblies. Over the last ten years the the-
ory of respiratory chain supercomplexes emerged — it is now widely
accepted that complexes of the respiratory chain organize into higher
molecular structures [93,94]. Apart from the stabilization of OXPHOS
complexes biogenesis, one of the proposed functions for super-
complexes is substrate channeling between individual respiratory
chain complexes leading to better protection from electron leak and
faster kinetics [95]. However, from the dehydrogenases supplying
electrons to the CoQ pool, only complex I is systematically identiﬁed
in supercomplexes. Kinetic evidence also proposes existence of sub-
strate channeling only for complex I and not for SDH, which seems
to communicate with complex III only via CoQ pool [95]. Unfortunate-
ly, due to the lack of speciﬁc inhibitors for mGPDH it is not possible to
perform such type of kinetic analysis for mGPDH. On the other hand,
there is some support that ﬂavin dehydrogenases may associate into
higher structures as well: (i) Isolated supercomplexes were found to
be respiratory active when using succinate as a substrate [93]. (ii) As-
sociation between fatty acid oxidation enzymes and OXPHOS com-
plexes has been described [96]. (iii) In yeast several mitochondrial
dehydrogenases including mGPDH analog Gut2p associate into supra-
molecular complex [97].
From the early isolation experiments it was obvious that mGPDH
forms higher molecular weight aggregates. Under non-denaturing
conditions of gel ﬁltration or native electrophoresis, the isolated
mGPDH “holoenzyme” migrated at a molecular weight of approxi-
mately 250–300 kDa and these complexes were considered to be
homooligomeric aggregates of the 74 kDa mGPDH monomers with
some bound detergent and phospholipids [10]. Multiple forms of en-
zyme were also suggested on the basis of bi- or multiphase thermal
denaturation proﬁles [7].
Homooligomers appear to be also present in digitonin solubilizates
of BAT mitochondria and may reﬂect the real in vivo organization of
the enzyme, as the bacterial GlpD is also active as dimer [13]. It is
also of note that in bacteria, SDH forms trimers, which are the active
conformation [98]. In addition, supercomplexes may also be formed
with proteins other than OXPHOS complexes. Apart from mGPDH
homooligomers, in digitonin solubilized BAT mitochondria we have
recently observed ~1 MDa big mGPDH containing supercomplexes
of yet unknown composition. But since this complex remains intact
in cells lacking assembled OXPHOS complexes I, III and IV, they most
likely represent an association of mGPDH with other proteins in the
inner mitochondrial membrane. Their signiﬁcance remains to be elu-
cidated [92].
8. Tissue speciﬁc (dys) functions of mGPDH
The general role of mGPDH and GP-shuttle in intermediary metab-
olism is well established, but its importance for different tissues andorgans may be connected with highly speciﬁc and diverse physiolog-
ical functions. This is illustrated by pathophysiological studies in BAT,
muscle, pancreas, sperm, or placenta as well as transgenic knock-out
models.
In contrast to dysfunctions of other respiratory chain dehydroge-
nases that cause inheritedmitochondrial OXPHOS disordersmanifesting
as progressive neurodegenerative diseases in case of SDH [99] and
NADH dehydrogenase [100], or glutaric acidemia type II in case of ETF:
Q dehydrogenase [101], no such a severe disorder due to mutation of
GPD2 gene has been reported yet. Numerous studies which focused on
potential signiﬁcance of mGPDH dysfunction indicate pathogenic ef-
fects to be associatedwith tissues wheremGPDH is highly active, name-
ly in pancreatic β cells, testis, brain or placenta but altered function of
mGPDH may affect metabolism in muscle and adipose tissue as well
and indirectly inﬂuence metabolism and energy balance of the whole
organism.
Animal models of mGPDH dysfunction, knock-outs of GPD2 gene
had generally milder and tissue speciﬁc phenotypes rather than
devastating consequences [102–104]. mGPDH knockout mice on a
C57BL/6J background had normal cold tolerance and normal thyroid
thermogenesis but 50% reduced viability and 40% reduction in the
weight of white adipose tissue [104]. In another model of mGPDH
knockout, mice had a small but distinct reduction in obligatory ther-
mogenesis despite increased plasma T4 and T3, whichwas compensated
by increased BAT facultative thermogenesis and by thyroid hormone-
dependent mechanisms using other proteins, possibly UCP3 [102].
These animals also had signiﬁcant alteration of intermediary metab-
olism primarily in muscle that leads to a thrifty phenotype more pro-
nounced in females [103]. This may reﬂect the fact that in its main
metabolic role, oxidation of cytosolic NADH, GP-shuttle can be sub-
stituted by malate/aspartate-shuttle. On the other hand, ablation of
both mGPDH and cGPDH resulted in lethal phenotype. Mice were
hypoglycemic, had elevated plasma fatty acids, developed ketonuria
and died within several days, indicating that in lipid metabolism,
mGPDH and cGPDH can substitute for each other but ablation of
both leads to its severe disturbances [105].
Despite these functional redundancies, alteration of mGPDH func-
tion appears to be associated with several pathological states as ap-
parent from studies on tissue speciﬁc roles of this enzyme.
Altered role of brain mGPDHwas suggested by a disruption of GPD2
gene by balanced reciprocal translocation 46,XX,t(2;7)(q24.1;q36.1)
that was found in a female patient exhibiting mild nonsyndromic men-
tal retardation. A twofold decrease of GPD2 transcript and decreased
mGPDH activity in patient's lymphoblastoid cell lines indicated that
functional defect of mGPDH could be associated with mental retarda-
tion. However, it was not found in other patients tested [106].
Muchmore convincing is the involvement of mGPDH in pathogen-
esis of polygenic disease, non-insulin dependent diabetes mellitus
(NIDDM). In pancreatic islets' β cells, many studies indicate signiﬁcant
participation of mGPDH and GP shuttle in the proximal events that
mediate release of insulin in response to increased glucose. Stimula-
tion of insulin secretion by glucose involves a rise in the cytoplasmic
concentration of Ca2+ [107] caused by the closure of ATP-sensitive
K+ channels in the plasma membrane, membrane depolarization,
and inﬂux of Ca2+ through voltage-sensitive channels [108,109]. An
important effect of glucose is also the ampliﬁcation of the action of
Ca2+ on the exocytotic process [110]. Both pathways require glucose
metabolism and appear to depend on a rise in the ATP/ADP ratio. Glu-
cose metabolism in β cells essentially occurs through aerobic glycoly-
sis [111]. The β cells have low activity of lactate dehydrogenase and
cytosolic NADH formed during glycolysis is re-oxidized by transfer
of the reducing equivalents into mitochondria through both GP- and
malate/aspartate-shuttles [28].
The importance of mGPDH for insulin secretion has been sup-
ported by its high activity in pancreatic islets [28,112] contrasting
with decreased mGPDH in islets of GK rats [113], db/db mice [114],
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in non-insulin dependent diabetic patients [117]. In some patients,
mutations in Ca2+ or FAD-binding domains of GPD2 gene were
found which can cause catalytic defect of mGPDH [118]. Furthermore,
autoantibodies reactive with pancreatic islets were found to cross
react with mGPDH antigen in IDDM but not NIDDM patients [119].
But neither could the studies on mGPDH knock-out demonstrate
changes in oscillatory responses of β cells to glucose [120] nor did
the overexpression of mGPDH correct impaired insulin secretion in
GK rats [121]. However, the strong experimental support for mGPDH
importance for β cell function came from studies of Eto et al. [122],
where it was clearly demonstrated, that glucose-induced insulin
release required oxidation of cytosolic NADH. The sole ablation of
mGPDH or the sole inhibition of aspartate aminotransferase by ami-
nooxyacetate had little or no effect, but their combination completely
abolished glucose-induced insulin release. Therefore, the defects in
shuttling of cytosolic NADH into mitochondria may contribute to im-
paired insulin secretion in non-insulin dependent diabetes mellitus.
Substitutable role of the shuttles may explain why modulation of
the mGPDH only was without clear effect on β cell function in some
other studies.
A substitutable role of the two shuttles is also demonstrated in
citrin deﬁciency [123]. Citrin, the liver-type aspartate/glutamate car-
rier participates in urea, protein, and nucleotide biosynthetic path-
ways by supplying aspartate from mitochondria to the cytosol and
also participates in transporting cytosolic NADH equivalents into
mitochondria as a component of the malate/aspartate-shuttle. Muta-
tions in SLC25A13 gene cause citrin deﬁciency manifesting as both
adult-onset type II citrulinemia and neonatal intrahepatic cholestasis.
Citrin knock-out mice failed to display features of human citrin deﬁ-
ciency but pathogenic phenotype was induced by double knock out
of citrin and GPD2 gene demonstrating that upregulation of GP shut-
tle activity was sufﬁcient to maintain to transport NADH equivalents
from cytosol to mitochondria in the absence of citrin [124]. Meta-
bolomic studies of double knockout further revealed a marked
increase of hepatic G3P, decrease of TCA intermediates, and alter-
ations of amino acid levels related to the urea cycle or lysine catabo-
lism [123].
An important biological role is played by mGPDH in sperm capac-
itation, in accordance with testis speciﬁc regulation of promoter C of
the GPD2 gene. Capacitation confers on the spermatozoa the compe-
tence to fertilize the oocyte. The mGPDH activity is very high in cau-
dal epididymal spermatozoa of rat and hamster and mGPDH activity
was found to correlate with sperm capacitation [30,125–127]. Immu-
noﬂuorescence studies demonstrated noncanonical localization in the
acrosome and principal piece in human, mouse, rat, and hamster
spermatozoa that may imply a role of mGPDH in acrosome reaction
and hyperactivation. Using mGPDH−/−mice Kota et al. demonstrated
that the absence of mGPDH signiﬁcantly alters hyperactivation and
acrosome reaction and reduces ROS generation in mouse spermato-
zoa which leads to impairment of sperm capacitation [126].
The signiﬁcance of mGPDH-dependent ROS production for metab-
olism of some mammalian tissues and cells is also illustrated by high
content of mGPDH in placenta and elevated levels in cancer cells. Ox-
idative stress in pregnancy, namely hypoxia/reoxygenation in the 1st
trimester results in increased oxygen tension that leads to increased
ROS production in placenta, associated with oxidative damage of pro-
teins and increase in expression of antioxidative enzymes [128]. Pla-
cental mitochondria were found to contain high amounts of mGPDH
[8,129] which may contribute to oxidative stress in placenta as anal-
ysis of human placental mitochondria demonstrated intensive
mGPDH-dependent ROS production [130].
Elevated levels of mGPDH were also found in rapidly growing,
undifferentiated tumors, while in undifferentiated slow growing tu-
mors the mGPDH activity was normal or decreased [131–133]. Most
malignant cells are highly glycolytic and produce high levels of ROScompared to normal cells. In prostate cancer cell lines (LNCaP, DU145,
PC3, and CL1)mGPDHabundance and activitywere signiﬁcantly elevat-
ed while cytochrome c oxidase activity was down-regulated. Conse-
quently, the glycolytic capacity and G3P-dependent ROS production
were increased and antioxidant enzymes SOD1, SOD2 and catalase
were up-regulated indicating that mGPDH is involved in maintaining
a high rate of glycolysis and is an important site of electron leakage
leading to ROS production in prostate cancer cells [134,135].
9. Conclusions
Original interest in mGPDH and its function in intermediary me-
tabolism led to the discovery of GP-shuttle and postulated the key
role of mGPDH in glycolysis, metabolism of fatty acids and oxidative
phosphorylation. Unique tissue speciﬁc expression was an attractive
aspect of mGPDH function that stimulated further research on its di-
verse physiological and organ speciﬁc functions. At present, new per-
spectives can be foreseen in elucidation of the involvement of mGPDH
in ROS production and oxidative stress in vivo, participation of enzyme
dysfunction in different pathological states and possible involvement
of mGPDH in supramolecular structures of mitochondrial enzymes
and components. It can be anticipated that these lines of future
research will beneﬁt from the detailed characterization of mGPDH
structure and function at atomic level, as it was the case with other re-
spiratory chain dehydrogenases.
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